Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-26

Clinical Trial Update: Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update exploring speech-in-noise treatments for hypophonia in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Parkinson Disease, Speech Disorders | Phase 2 | Status: UNKNOWN